Guneet Sodhi, MD
Retina Specialist · Edina, MNNPI 1083069926
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,845 of the $3,495 with a category attached, or 81.4%. Genentech USA, Inc. accounts for 60.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $2,126 and has fallen 65.7% since, to $730 in 2025.
Across 7 payments — averaging $499.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$2K
- Genentech, Inc.$730
- Alcon$429
- Optos, Inc.$210
What the payments were for
- Consulting fees$2,84581%
- Food & beverage$65019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 3 | $2,126 |
| Genentech, Inc. | 1 | $730 |
| Alcon | 2 | $429 |
| Optos, Inc. | 1 | $210 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$2,845
- SUSVIMO$730
- PANORAMIC OPHTHALMOSCOPE$420
- OCT OPHTHALMOSCOPE$210
- NFC-700$210
How this compares
$3,495 in reported general payments places this provider in the 70th percentile of 20 retina specialist providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 245 | $12,964 |
| Ketorolac Tromethamine | 108 | $2,321 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $976 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 102 | $804 |
| Atropine Sulfate | 16 | $461 |
| Latanoprost | 33 | $366 |
| Brimonidine Tartrate | 27 | $226 |
| Timolol Maleate | 21 | $201 |
| Dorzolamide Hcl | 11 | $181 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $177 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Edina
- Zeeshan HaqEdina$12K
- Michael MaywoodEdina$5K
- Sahal SalehEdina$3K
- Vincent VannEdina$300
- Richard JohnstonEdina$284
- Tommaso VagagginiEdina$139
- Paul DraynaEdina$28
- Malav JoshiRochester$293K
- Abdhish BhavsarMinneapolis$21K
- David WilliamsBaxter$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.